Orwyn logoorwyn
Working with the NHS

Developed with the people who do the work.

The size of the problem

Musculoskeletal problems are one of the biggest things the NHS deals with. 20 million people in the UK live with a musculoskeletal condition. Up to 30% of general practice consultations in England relate to one. The NHS spends around £5 billion a year on them, and around 30.6 million working days are lost to them every year.

ARMA, the alliance of patient charities and professional bodies that speaks for musculoskeletal health in the UK, describes what good care needs: early assessment, rapid advice and appropriate triage, so people get the right support before problems escalate, and strong links between community services and specialist care. Delays, they note, lead to avoidable deterioration, loss of function and increased pressure on the rest of the system.

The GP consultation figure is published by NHS England. The remaining figures and the policy positions are published by ARMA, the Arthritis and Musculoskeletal Alliance. Orwyn has no affiliation with either and is endorsed by neither.

The scale of musculoskeletal care Four current musculoskeletal burden statistics: more than 20 million people affected, up to 30 percent of GP consultations, around 5 billion pounds annual NHS spending, and around 30.6 million working days lost. 20m+peoplein the UK live with an MSKcondition.Source: NHS EnglandUp to 30%GP consultationsin England relate to MSKconditions.Source: NHS England££5bnNHS spendestimated annually on MSKconditions.Source: ARMA 202630.6mworking dayslost annually to MSK conditions.Source: ARMA 2026
The scale of musculoskeletal care in the NHS. Figures published by NHS England and by ARMA, the Arthritis and Musculoskeletal Alliance.

For services that commission musculoskeletal care

ARMA's analysis of every integrated care board's joint forward plan found that 1 in 3 do not meaningfully reference musculoskeletal health, and 2 in 3 do not reference chronic pain services. Their recommendation is a joined up approach across the whole system, with clear outcomes for the services being bought, and services measured on function and participation rather than on activity.

Orwyn is designed to improve the value of existing MSK pathways, reducing avoidable downstream activity while identifying patients who need specialist review sooner. It is built for one moment inside the spending that already happens: the point where the clinician seeing the patient first decides whether that patient needs a surgical opinion. Get that moment right and the patients who need an operation are found sooner, and the patients who do not are given a clear answer instead of a year of waiting to be told so. Because every decision is recorded with the reason for it, what happens next can be counted. This is the work NHS England calls MSK referral optimisation, and it is judged in both directions rather than on referral volume alone.

Better decisions, better care Four intended benefits of Orwyn: earlier specialist review when indicated, fewer unnecessary waits, less uncertainty, and structured outcome data. These are design intentions, not results. Orwyn has not yet been deployed. Better decisions. Better care. Designed to findsurgical patients soonerBuilt to identify people whoneed specialist review earlier. Fewer unnecessary waitsGive patients a clear, crediblenon-surgical plan. Less uncertaintyIntended to reduce avoidablewaits and improve experience. Know what happenedStructured outcome data to improvepathways. Design intentions, not results. Orwyn has not yet been deployed.
What Orwyn is designed to change. These are design intentions, not results: Orwyn has not yet been deployed.

For musculoskeletal triage and first contact services

Orwyn is for the clinician, in the room, while the patient is in front of them. It is clinician-facing decision support, not a patient questionnaire and not something the patient fills in at home. It fits inside a normal appointment and it does not slow the appointment down.

Every suggestion comes with the reason for it, in plain words. The clinician can disagree and record why, and that disagreement is kept. Orwyn does not check, approve or oversee anyone's work. It carries a surgeon's judgement into a room the surgeon is not in, and the clinician assesses the patient and decides.

For general practice

General practice still sees most musculoskeletal presentations, in ten minute appointments, alongside everything else. The hardest cases are often the ones already waiting, who keep coming back, where the honest question is whether anything has been missed and whether the plan should change.

Orwyn is designed and tested for first contact musculoskeletal appointments rather than for a ten minute general practice appointment. We are talking to GPs now about whether it is useful in general practice and what would have to change. If you see these patients, we would like to hear from you.

Pilot measurement map A four-part pilot evaluation pathway covering the referral decision, specialist outcome, patient pathway and service effect. A pilot should measure what changed. Not clicks. Not logins. The clinical decision, the outcome, and the pathway around it. 1Referral decisionWhat was decided, and why2Specialist outcomeWhat happened downstream3Patient pathwayTime, reattendance, escalation4Service effectActivity, waits, variation, cost Designed for NHS pilot evaluation: baseline, then decision, then downstream outcome, then service-level effect.
What a pilot should measure: the decision, the downstream outcome, the patient pathway and the effect on the service.
Decision support for clinicians only. The clinician assesses the patient and makes every decision. Orwyn is not a service for patients and gives no advice directly to patients or the public.